
Overview
Gwynn Long is a Transplant Surgeon practicing medicine in Durham, North Carolina. He has been practicing medicine for over 43 years.
Dr. Long is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.
Dr. Long is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 2 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Long has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Crawford is board certified in American Board Of Internal Med, Hematology/Oncology , American Board Of Internal Med, Internal Medicine , and American Board Of Internal Med, Medical Oncology.
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
Michael Morse is a Hematologist Oncology specialist and an Oncologist practicing medicine in Durham, North Carolina. He has been practicing medicine for over 36 years. Dr. Morse is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Appendix Cancer, and Liver Embolization. Dr. Morse is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.
Frequently Asked Questions about Dr. Gwynn D. Long
How do I make an appointment with Dr. Gwynn D. Long?
You can book an appointment with Dr. Gwynn D. Long by calling their office at 919-668-1002. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gwynn D. Long a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gwynn D. Long is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gwynn D. Long specialize in?
While Dr. Gwynn D. Long is a Hematology Oncology, they have specific expertise in Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Gwynn D. Long participate in research or clinical trials?
Yes. Dr. Gwynn D. Long has published 49 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Gwynn D. Long's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gwynn D. Long accept my insurance?
Dr. Gwynn D. Long accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-668-1002 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Long isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Long isDistinguished. Learn about Bone Marrow Transplant.
- Multiple MyelomaDr. Long isDistinguished. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Long isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid Leukemia
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)
- Myelodysplastic Syndrome (MDS)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Long isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myelomonocytic LeukemiaDr. Long isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult T-Cell LeukemiaDr. Long isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Long isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Long isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Long isExperienced. Learn about B-Cell Lymphoma.



